News
Roche has found redemption in a precision medicine approach following an earlier Tecentriq trial flop in a broader bladder ...
With a win in a D.C. appeals court, Vanda Pharmaceuticals has earned a point over the FDA in the years-long face-off between ...
Ever since taking his seat as Secretary of the U.S. Health and Human Services (HHS) under a banner of “radical transparency,” ...
Sarepta Therapeutics has provided additional safety data on its gene therapy Elevidys as a Duchenne muscular dystrophy ...
With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...
Several months after unveiling its direct-to-consumer NovoCare Pharmacy service with the launch of a $499 cash-pay option for ...
The FOB5 Sets a New Benchmark for Pharma and Biotech Labs | Discover how Fedegari’s FOB5 is redefining sterilization with ...
Every year, we celebrate women making a powerful impact across biopharma and medtech, and it’s time once again to make your ...
Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. | Tonix Pharmaceuticals was ...
After taking a $50 million hit in a patent lawsuit targeting its leukemia med Blincyto last year, Amgen has convinced a ...
FluMist has been approved since 2003, but—until last year—only for administration by a healthcare practitioner. The new nod ...
The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results